Akèy › Kansè Poumon ki pa ti selil › New York › Queens
Etid klinik pou Kansè Poumon ki pa ti selil nan Queens, NY
49 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Queens (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 2
- Clinical Research Alliance - Westbury /ID# 270455, Westbury · 14 mi lwen
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi lwen
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- START New York Long Island LLC, Lake Success · 9 mi lwen
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Ap rekriteFaz 2/3
- NYU Langone Hospital Long Island, Mineola · 11 mi lwen
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Ap rekriteFaz 3
- New York Cancer & Blood Specialists - New Hyde Park, New Hyde Park · 9 mi lwen
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Ap rekriteFaz 3
- Optum Medical Care, PC, Westbury · 14 mi lwen
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Ap rekriteFaz 3
- Local Institution - 0224, Laurelton · 5 mi lwen
- Optum Medical Care, PC, Westbury · 14 mi lwen
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Ap rekriteFaz 3
- Optum Medical Care, PC, Westbury · 14 mi lwen
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Ap rekriteFaz 3
- Research Site, Fresh Meadows · 4 mi lwen
- Research Site, Westbury · 14 mi lwen
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 2
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi lwen
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Ap rekriteFaz 2/3
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi lwen
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Ap rekriteFaz 1/2
- START New York, Lake Success · 9 mi lwen
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 3
- Research Site, Westbury · 14 mi lwen
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
Ap rekriteFaz 1
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi lwen
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi lwen
Using Urine Samples to Identify Lung Cancer
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi lwen
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi lwen
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Ap rekriteFaz 1
- Site 107 - START New York - Long Island, Lake Success · 9 mi lwen
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
Ap rekriteFaz 1/2
- NYU Langone Hospital - Long Island, Mineola · 11 mi lwen
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 mi lwen
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi lwen
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Clinical Research Alliance, Westbury · 14 mi lwen
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Ap rekriteFaz 1
- NYU Langone Health - Long Island, Mineola · 11 mi lwen
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Ap rekriteFaz 1
- START NY Long Island, Lake Success · 9 mi lwen
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Ap rekriteFaz 1/2
- START New York Long Island, New Hyde Park · 9 mi lwen
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Ap rekriteFaz 1
- Perlmutter Cancer Center at NYU Langone Hospital Long Island, Mineola · 11 mi lwen
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Ap rekrite
- Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre · 10 mi lwen
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Ap rekriteFaz 3
- Northwell Health/R.J. Zuckerberg Cancer Center, Lake Success · 9 mi lwen
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Ap rekriteFaz 3
- NYU Langone Hospital - Long Island, Mineola · 11 mi lwen
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
A Study of MGC026 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- START-New York Long Island, Lake Success · 9 mi lwen
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Ap rekriteFaz 1/2
- Northwell Health, Lake Success · 9 mi lwen
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Ap rekriteFaz 3
- Queens Cancer Center, Rego Park · 3 mi lwen
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi lwen
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi lwen
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Nassau (Consent Only), Uniondale · 13 mi lwen
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Ap rekriteFaz 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park · 9 mi lwen
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon · 27 mi lwen
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Ap rekriteFaz 1/2
- Clinical Research Alliance, Westbury · 14 mi lwen
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Ap rekriteFaz 3
- New York Cancer & Blood Specialists (NYCBS), New Hyde Park · 9 mi lwen
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Ap rekriteFaz 1
- START New York Long Island, LLC, Lake Success · 9 mi lwen
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- START New York Long Island, LLC, Lake Success · 9 mi lwen
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi lwen
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre · 10 mi lwen
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10 mi lwen
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi lwen
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- Queens Hospital Center, Jamaica · 2 mi lwen
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi lwen
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Hempstead · 12 mi lwen
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY121 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH57 etid
- Washington, DC55 etid
Lòt etid nan Queens
- Kansè nan tete64 etid
- Kansè kolorektal31 etid
- Kansè Metastatik28 etid
- Kansè ovè28 etid
- Kansè pwostat27 etid
- Kansè (tout kalite)26 etid
- Kansè Endomèt25 etid
- Kansè poumon22 etid
- Leksemi mieloïd egi21 etid
- Myelom Miltip20 etid
- Kansè pankreyas20 etid
- Karsinòm selil skuamèz tèt ak kou20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.